We are live on ! Find out more
Primecap Management

Primecap Management Portfolio holdings

AUM $127B
1-Year Est. Return 44.11%
This Fund
S&P 500
This Quarter Est. Return
+8.27%
1 Year Est. Return
+44.11%
3 Year Est. Return
+121.64%
5 Year Est. Return
+154.22%
10 Year Est. Return
+724.54%
AUM
$144B
AUM Growth
+$2.8B
Cap. Flow
-$5.9B
Cap. Flow %
-4.09%
Top 10 Hldgs %
29.72%
Holding
347
New
10
Increased
58
Reduced
237
Closed
5

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$187M
2
INTC icon
Intel
INTC
+$174M
3
AUR icon
Aurora
AUR
+$114M
4
BABA icon
Alibaba
BABA
+$86.2M
5
LUNG icon
Pulmonx
LUNG
+$72M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$763M
2
TSLA icon
Tesla
TSLA
+$478M
3
ADBE icon
Adobe
ADBE
+$327M
4
MSFT icon
Microsoft
MSFT
+$319M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$243M

Sector Composition

Rank Sector Weight
1 Technology 32.19%
2 Healthcare 26%
3 Industrials 11.45%
4 Consumer Discretionary 10.92%
5 Financials 10.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CE icon
326
Celanese
CE
$4.82B
$1.34M ﹤0.01%
8,000
VLRS
327
Controladora Vuela Compania de Aviacion
VLRS
$939M
$1.29M ﹤0.01%
72,000
MSGS icon
328
Madison Square Garden
MSGS
$9.39B
$1.18M ﹤0.01%
6,773
AWI icon
329
Armstrong World Industries
AWI
$7.84B
$1.16M ﹤0.01%
10,000
MBII
330
DELISTED
Marrone Bio Innovations, Inc.
MBII
$1.14M ﹤0.01%
1,583,800
-116,200
-7% -$94K
CNR
331
DELISTED
Cornerstone Building Brands, Inc.
CNR
$1.13M ﹤0.01%
65,000
-50,000
-43% -$776K
BE icon
332
Bloom Energy
BE
$64.6B
$1.09M ﹤0.01%
49,600
ULCC icon
333
Frontier Group Holdings
ULCC
$1.7B
$973K ﹤0.01%
71,700
AVO icon
334
Mission Produce
AVO
$1.17B
$734K ﹤0.01%
46,720
-8,150
-15% -$152K
MQ icon
335
Marqeta
MQ
$1.66B
$561K ﹤0.01%
8,175
-200
-2% -$17.9K
OLK
336
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
$546K ﹤0.01%
30,000
-3,000
-9% -$74K
MREO
337
Mereo BioPharma
MREO
$47.3M
$532K ﹤0.01%
332,200
-7,400
-2% -$14.8K
TXG icon
338
10x Genomics
TXG
$6.61B
$492K ﹤0.01%
3,300
-4,350
-57% -$666K
CELL
339
DELISTED
PhenomeX Inc. Common Stock
CELL
$475K ﹤0.01%
26,145
+1,487
+6% +$32.1K
DMRC icon
340
Digimarc Corp
DMRC
$178M
$403K ﹤0.01%
10,200
-33,800
-77% -$1.47M
BYND icon
341
Beyond Meat
BYND
$277M
$215K ﹤0.01%
3,300
-15,500
-82% -$1.32M
SIOX
342
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$26K ﹤0.01%
20,100
-31,700
-61% -$56.3K
ARE icon
343
Alexandria Real Estate Equities
ARE
$8.56B
-25,000
Closed -$4.78M
MGNI icon
344
Magnite
MGNI
$3.55B
-266,500
Closed -$7.46M
VFC icon
345
VF Corp
VFC
$5.89B
-25,000
Closed -$1.68M
AUD
346
DELISTED
Audacy, Inc.
AUD
-924,300
Closed -$3.4M
VG
347
DELISTED
Vonage Holdings Corporation
VG
-620,100
Closed -$10M

Similar funds

Primecap Management's Q4 2021 Portfolio in Review

As of Q4 2021, Primecap Management held 347 positions worth $144B, up 2% from $142B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Primecap Management withdrew a net $5.9B in Q4 2021, closing 5 positions and reducing 237 holdings. Its most notable exit was Vonage Holdings Corporation, an estimated $10M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Primecap Management opened a new position in Aurora worth $116M.

  • Primecap Management's largest Q4 2021 buy was Aurora: 10,279,870 shares worth $116M.
  • Primecap Management added most to Bristol-Myers Squibb in Q4 2021, an estimated $187M increase.
  • Primecap Management's biggest Q4 2021 reduction was Eli Lilly, cutting an estimated $763M.
  • Primecap Management fully exited Vonage Holdings Corporation in Q4 2021, selling an estimated $10M.
  • Primecap Management's ten largest holdings make up 30% of its $144B portfolio in Q4 2021.
  • Primecap Management opened 10 new positions and closed 5 in Q4 2021.
  • Primecap Management's portfolio value rose 2% quarter-over-quarter to $144B.

Based on Primecap Management's 13F filing for Q4 2021, filed 11 Feb 2022.